(R)-2-((Tert-butoxycarbonyl)amino)-3,3,3-trifluoropropanoic acid is a chiral, non-natural amino acid derivative. Its structure features a trifluoromethyl group at the beta-position and a Boc-protected amino group, making it a valuable building block for introducing the unique properties of fluorine into bioactive molecules. This compound is primarily used as a key chiral intermediate in pharmaceutical research and development. The trifluoromethyl group is known to enhance metabolic stability, lipophilicity, and bioavailability of drug candidates. Therefore, this specific (R)-enantiomer is employed in the synthesis of peptides and peptidomimetics for potential therapeutic applications, particularly in the design of protease inhibitors and other biologically active compounds where fluorine substitution is desired. As a Boc-protected amino acid, it is a convenient reagent for solid-phase peptide synthesis (SPPS) and other fragment-coupling strategies. Its high purity and defined chirality are critical for ensuring the stereochemical integrity of the final target molecules in medicinal chemistry campaigns.